4
Dec. 17, 2024
On September 30, the FDA removed tirzepatide from the shortage list, creating confusion for patients and providers who rely on compounding pharmacies. Vickie Paesano, third-generation owner of Preston’s Pharmacy, a trusted pharmacy serving 27 states, shares insights as both a pharmacist and the owner of Core Aesthetic, her med spa. Bill and Vickie discuss: What some pharma reps are doing on the ground to circumvent the provider relationship and block compounded versions of tirzepatide How the...